By: Leah Lawrence From: cancertherapyadvisor.com A new study has attempted to identify several biomarkers associated with metaplastic breast carcinoma (MBC), a highly aggressive form of triple-negative breast cancer (TNBC). “Clinically, MBCs are more metastatic and chemoresistant than nonmetaplastic TNBC, with the spindle subtype reported to have the worst prognosis,” the researchers wrote. “This significant clinical challenge highlights the need to …